Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival
Smith, M P
AffiliationManchester Cancer Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester
MetadataShow full item record
AbstractMelanoma is the deadliest form of skin cancer; a primary driver of this high level of morbidity is the propensity of melanoma cells to metastasize. When malignant tumours develop distant metastatic lesions the new local tissue niche is known to impact on the biology of the cancer cells. However, little is known about how different metastatic tissue sites impact on frontline targeted therapies. Intriguingly, melanoma bone lesions have significantly lower response to BRAF or MEK inhibitor therapies. Here, we have investigated how the cellular niche of the bone can support melanoma cells by stimulating growth and survival via paracrine signalling between osteoblasts and cancer cells. Melanoma cells can enhance the differentiation of osteoblasts leading to increased production of secreted ligands, including RANKL. Differentiated osteoblasts in turn can support melanoma cell proliferation and survival via the secretion of RANKL that elevates the levels of the transcription factor MITF, even in the presence of BRAF inhibitor. By blocking RANKL signalling, either via neutralizing antibodies, genetic alterations or the RANKL receptor inhibitor SPD304, the survival advantage provided by osteoblasts could be overcome.
CitationFerguson J, Wilcock DJ, McEntegart S, Badrock AP, Levesque M, Dummer R, et al. Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival. Pigment Cell Melanoma Res. 2019 Jul 19.
JournalPigment Cell & Melanoma Research
- Systemic treatments for metastatic cutaneous melanoma.
- Authors: Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S
- Issue date: 2018 Feb 6
- NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.
- Authors: Flockhart RJ, Armstrong JL, Reynolds NJ, Lovat PE
- Issue date: 2009 Oct 20
- CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
- Authors: Yu X, Huang Y, Collin-Osdoby P, Osdoby P
- Issue date: 2004 Dec
- Genetic progression of malignant melanoma.
- Authors: Tímár J, Vizkeleti L, Doma V, Barbai T, Rásó E
- Issue date: 2016 Mar
- Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
- Authors: Kundu A, Quirit JG, Khouri MG, Firestone GL
- Issue date: 2017 Jan